Home › Slokdarmkanker › Michigan › Grand Rapids
Slokdarmkanker klinische studies in Grand Rapids, MI
14 studies voor Slokdarmkanker zoeken deelnemers op locaties in en rond Grand Rapids (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruterenFase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruterenGezonde vrijwilligers welkom
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Pan-tumor MRD Study
RekruterenObservatieonderzoek
- The Cancer & Hematology Centers (CHC), Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruterenFase 1
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruterenObservatieonderzoek
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruterenFase 3
- Research Site, Grand Rapids
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RekruterenFase 1/2
- The Cancer and Hematology Centers ( Site 8912), Grand Rapids
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
RekruterenFase 1/2
- The Cancer and Hematology Centers ( Site 6912), Grand Rapids
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruterenFase 1
- START Midwest /ID# 248685, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RekruterenFase 1/2
- START Midwest, Grand Rapids
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
RekruterenFase 1/2
- BAMF Health, Inc., Grand Rapids
Slokdarmkanker studies in andere steden
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Pittsburgh, PA15 studies
- Los Angeles, CA15 studies
- Baldwin Park, CA14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Rochester, MN11 studies
- Chicago, IL11 studies
Andere studies in Grand Rapids
- Niet-kleincellige longkanker44 studies
- Colorectale kanker40 studies
- Kanker (alle vormen)28 studies
- Borstkanker26 studies
- Eierstokkanker24 studies
- Metastatische kanker22 studies
- Prostaatkanker19 studies
- Endometriumkanker18 studies
- Maagkanker18 studies
- Aldermeesklierkanker18 studies
- Melanoom17 studies
- Plaveiselcelcarcinoom van hoofd en hals15 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.